We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Cardinal Health (CAH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of CAH and the rest of the Medical group's stocks.
Cardinal Health is one of 833 companies in the Medical group. The Medical group currently sits at #2 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. CAH is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for CAH's full-year earnings has moved 1.22% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that CAH has returned about 13.34% since the start of the calendar year. In comparison, Medical companies have returned an average of 10.46%. As we can see, Cardinal Health is performing better than its sector in the calendar year.
To break things down more, CAH belongs to the Medical - Dental Supplies industry, a group that includes 20 individual companies and currently sits at #57 in the Zacks Industry Rank. On average, stocks in this group have gained 13.44% this year, meaning that CAH is slightly underperforming its industry in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track CAH. The stock will be looking to continue its solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Cardinal Health (CAH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of CAH and the rest of the Medical group's stocks.
Cardinal Health is one of 833 companies in the Medical group. The Medical group currently sits at #2 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. CAH is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for CAH's full-year earnings has moved 1.22% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that CAH has returned about 13.34% since the start of the calendar year. In comparison, Medical companies have returned an average of 10.46%. As we can see, Cardinal Health is performing better than its sector in the calendar year.
To break things down more, CAH belongs to the Medical - Dental Supplies industry, a group that includes 20 individual companies and currently sits at #57 in the Zacks Industry Rank. On average, stocks in this group have gained 13.44% this year, meaning that CAH is slightly underperforming its industry in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track CAH. The stock will be looking to continue its solid performance.